Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05859295 · ClinicalTrials.gov registry record · NA
Evaluation of Low-Level Light Therapy on Meibomian Glands Study
A NA study, sponsored by University of Houston.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT05859295 is a NA study that has completed, run by University of Houston. The registered enrollment target is 30 participants.
The verdict
NCT05859295, a NA study, has completed, sponsored by University of Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to examine the effect of low-level light therapy (LLLT) on meibomian gland dysfunction and dry eye disease. The main questions it aims to answer are: 1. Does low-level light therapy reduce levels of pro-inflammatory proteins in meibum 2. Does low-level light therapy increase the ratio of non-polar lipids to polar lipids in meibum Participants will receive 3 15-minute sessions of low-level light therapy. Meibum will be collected before the first treatment and after the final treatment.
Interventions
- DEVICE Red Low-Level Light Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-06-07 |
| Est. Completion | 2023-11-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05859295
The ClinicalTrials.gov registry entry for NCT05859295 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Houston, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Red Low-Level Light Therapy is the first listed.
NCT05859295 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05859295 about?
NCT05859295 is a clinical study titled "Evaluation of Low-Level Light Therapy on Meibomian Glands Study". The goal of this clinical trial is to examine the effect of low-level light therapy (LLLT) on meibomian gland dysfunction and dry eye disease. The main questions it aims to answer are: 1. Does low-level light therapy reduce levels of pro-inflammatory proteins in meibum 2. Does low-level light thera...
What is the current status of trial NCT05859295?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2023-06-07. Estimated completion is 2023-11-11.
What interventions are being tested in trial NCT05859295?
The interventions under investigation include: Red Low-Level Light Therapy (DEVICE).
Who is sponsoring clinical trial NCT05859295?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.